Sylvie Freeman

ORCID: 0000-0003-1869-180X

Colleges, School and Institutes

External positions

, Weatherall Institute of Molecular Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.

1 Oct 2017 → …
View graph of relations

Most downloaded publications

Assessment of minimal residual disease in standard-risk AML
4 Feb 2016, In: The New England Journal of Medicine. 374, 5, p. 422-433 12 p.

Research output: Contribution to journal › Article › peer-review

220 downloads
Minimal/measurable residual disease in AML: consensus document from ELN MRD Working Party
Sylvie Freeman & 4 others, , 12 Jan 2018, In: Blood.

Research output: Contribution to journal › Article › peer-review

196 downloads
Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage
& 13 others, , Sylvie Freeman, Charles Craddock, 25 Jul 2016, In: The Journal of Experimental Medicine. 213, 8, p. 1513-35 23 p.

Research output: Contribution to journal › Article › peer-review

184 downloads
A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia
Robert Hills, Sylvie Freeman, 30 Sep 2016, In: Leukemia.

Research output: Contribution to journal › Article › peer-review

171 downloads
Measurable residual disease at induction redefines partial response in acute myeloid leukemia and stratifies outcomes in patients at standard risk without NPM1 mutations
Sylvie Freeman, Naeem Khan, 20 May 2018, In: Journal of Clinical Oncology . 36, 15, p. 1486-1497 12 p.

Research output: Contribution to journal › Article › peer-review

129 downloads

Recent publications

Augmented reduced-intensity regimen does not improve postallogeneic transplant outcomes in acute myeloid leukemia
Charles Craddock, Aimee Jackson, Justin Loke, Ram Malladi, Keith Wheatley & 7 others, , Naeem Khan & Sylvie Freeman, 29 Dec 2020, In: Journal of Clinical Oncology . 12 p., JCO2002308.

Research output: Contribution to journal › Article › peer-review

Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses
Sylvie Freeman, 23 Dec 2020, In: Journal of Clinical Oncology . p. JCO2001170

Research output: Contribution to journal › Article › peer-review

Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-analysis.
Sylvie Freeman, Oct 2020, In: JAMA Oncology.

Research output: Contribution to journal › Article › peer-review

View all (48)